Neil B. Minkoff, MD

October 21, 2021

Key takeaways from the National Kidney Foundation’s new HEDIS and MIPS quality measures for patients with chronic kidney disease and type 2 diabetes.

October 21, 2021

Various types of health care professionals who may play a role in treating patients with chronic kidney disease, and recommendations to help overcome barriers that impact risk of disease progression and outcomes for patients.

October 20, 2021

Panelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.

October 18, 2021

Expert panelists consider how to define response to disease-modifying therapies and discuss the threshold for treatment ineligibility due to lack of response.

October 14, 2021

Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression.

October 14, 2021

A panel of clinicians explain why action is needed to help prevent the risk of progression of chronic kidney disease.

October 13, 2021

A member of the American Brain Foundation discusses the organization’s role in the development of Alzheimer disease management and improvement in education.

October 11, 2021

Key opinion leaders discuss possible ways to mitigate the increased cost of Alzheimer disease treatment.

October 07, 2021

Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community.

October 07, 2021

Strategies to help clinicians talk with patients about chronic kidney disease staging and what to expect in terms of prognosis.